State Street SPDR S&P Biotech ETF (XBI) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Broad Market / FactorSector
- $164.2852W High
- $85.1652W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track State Street SPDR S&P Biotech ETF (XBI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $85.16 and a high of $164.28, highlighting its annual price range. Buy and sell State Street SPDR S&P Biotech ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
VanEck BDC Income ETF halves July payout amid pressure on underlying BDCs' dividends.
The VanEck BDC Income ETF (BIZD) cut its July distribution to $0.24 per share, half of April's $0.48, reflecting stress in its underlying business development companies (BDCs) due to rate cuts and spread compression. Key BDC holdings like Blue Owl Ca...

Investor advises patience on SpaceX, bullish on Meta and Micron amid tech and AI optimism
David H. Lerner highlights cautious optimism for SpaceX due to current valuation and expected volatility around the Starship launch, recommending patience before buying. Meta Platforms is gaining momentum driven by AI initiatives, prompting Lerner to...

REX AI Equity Premium Income ETF shifts to weekly payouts, but income sustainability is uncertain.
The REX AI Equity Premium Income ETF (AIPI) changed its distribution schedule from monthly to weekly payments while maintaining a similar annual yield near 35%. The fund generates income by selling call options on AI-focused stocks like Palantir and ...
